Recurrent dermatofibrosarcoma protuberans treated with neoadjuvant imatinib mesylate followed by Mohs micrographic surgery

by Natalia M. Fontecilla, BA, Nicole W. Kittler, MD, Larisa Geskin, MD, Faramarz H. Samie, MD, PhD, George Niedt, MD, Thomas Imahiyerobo, MD, Gary Schwartz, MD, Matt Ingham, MD, Jesse M. Lewin, MD
Published 2017-11-01